Countries in the Balkan region use pharmaco-economic data for decisions about the inclusion of new pharmaceuticals into their positive drug lists, but no predefined frameworks are used and resources for health technology assessment (HTA) are limited. The goal of this analysis is to investigate into possible development directions for the HTA system in the region, and provide some practical recommendations for a sustainable model. For this purpose, the main factors currently influencing HTA in Balkan countries are briefly presented, and possible development strategies are compared. A resource-saving balanced assessment approach is proposed. It is aligned with available resources and capabilities, and helps access to new pharmaceuticals while ensuring the transparency of decision-making processes and the stability of the pharmaceutical budget.

中文翻译：

---

巴尔干地区的卫生技术评估：平衡药物评估系统的机会

巴尔干地区的国家使用药物经济数据来决定将新药纳入其阳性药物清单，但没有使用预定义的框架，卫生技术评估 (HTA) 的资源有限。本次分析的目的是探讨该地区 HTA 系统可能的发展方向，并为可持续模式提供一些实用建议。为此，简要介绍了目前影响巴尔干国家 HTA 的主要因素，并比较了可能的发展战略。提出了一种资源节约平衡评估方法。它与可用资源和能力保持一致，有助于获得新药，同时确保决策过程的透明度和药品预算的稳定性。